Annual SGA
$10.74 M
-$1.25 M-10.42%
December 31, 2023
Summary
- As of February 10, 2025, FWBI annual SGA is $10.74 million, with the most recent change of -$1.25 million (-10.42%) on December 31, 2023.
- During the last 3 years, FWBI annual SGA has risen by +$3.44 million (+47.20%).
Performance
FWBI SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$8.66 M
+$5.87 M+210.81%
March 31, 2024
Summary
- As of February 10, 2025, FWBI quarterly SGA is $8.66 million, with the most recent change of +$5.87 million (+210.81%) on March 31, 2024.
- Over the past year, FWBI quarterly SGA has increased by +$5.87 million (+210.81%).
Performance
FWBI Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$720.11 M
-$6.16 M-0.86%
March 31, 2024
Summary
- As of February 10, 2025, FWBI TTM SGA is -$720.11 million, with the most recent change of -$6.16 million (-0.86%) on March 31, 2024.
- Over the past year, FWBI TTM SGA has dropped by -$730.85 million (-6806.51%).
Performance
FWBI TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
FWBI Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.4% | +210.8% | -6806.5% |
| 3 y3 years | +47.2% | +210.8% | -6806.5% |
| 5 y5 years | +44.1% | +210.8% | -6806.5% |
FWBI Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.6% | at low | at high | -74.9% | +40.6% | at low |
| 5 y | 5-year | -41.6% | -43.5% | at high | -95.7% | +208.4% | at low |
| alltime | all time | -41.6% | -69.0% | at high | -95.7% | +8580.8% | at low |
First Wave BioPharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $8.66 M(+210.8%) | $16.70 M(+55.5%) |
| Dec 2023 | $10.74 M(-10.4%) | $2.79 M(+15.0%) | $10.74 M(+6.0%) |
| Sep 2023 | - | $2.42 M(-14.4%) | $10.13 M(-4.5%) |
| Jun 2023 | - | $2.83 M(+4.7%) | $10.61 M(+3.2%) |
| Mar 2023 | - | $2.70 M(+24.0%) | $10.28 M(-14.2%) |
| Dec 2022 | $11.99 M(-34.8%) | $2.18 M(-25.0%) | $11.99 M(-6.7%) |
| Sep 2022 | - | $2.90 M(+16.2%) | $12.85 M(-19.5%) |
| Jun 2022 | - | $2.50 M(-43.3%) | $15.96 M(-6.6%) |
| Mar 2022 | - | $4.41 M(+45.1%) | $17.09 M(-7.0%) |
| Dec 2021 | $18.38 M(+152.0%) | $3.04 M(-49.6%) | $18.38 M(+1.9%) |
| Sep 2021 | - | $6.02 M(+65.9%) | $18.05 M(+29.4%) |
| Jun 2021 | - | $3.63 M(-36.3%) | $13.94 M(+20.0%) |
| Mar 2021 | - | $5.70 M(+111.1%) | $11.62 M(+59.2%) |
| Dec 2020 | $7.29 M(+20.3%) | $2.70 M(+40.8%) | $7.30 M(+46.8%) |
| Sep 2020 | - | $1.92 M(+46.9%) | $4.97 M(+1.1%) |
| Jun 2020 | - | $1.30 M(-5.4%) | $4.92 M(-13.3%) |
| Mar 2020 | - | $1.38 M(+269.8%) | $5.67 M(-3.6%) |
| Dec 2019 | $6.06 M | $373.10 K(-79.9%) | $5.88 M(-22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $1.86 M(-9.5%) | $7.56 M(+7.7%) |
| Jun 2019 | - | $2.06 M(+29.0%) | $7.02 M(-1.6%) |
| Mar 2019 | - | $1.59 M(-22.2%) | $7.13 M(-4.3%) |
| Dec 2018 | $7.45 M(-3.1%) | $2.05 M(+55.6%) | $7.45 M(-0.9%) |
| Sep 2018 | - | $1.32 M(-39.2%) | $7.52 M(-8.4%) |
| Jun 2018 | - | $2.17 M(+13.1%) | $8.21 M(+10.6%) |
| Mar 2018 | - | $1.92 M(-9.6%) | $7.43 M(-3.4%) |
| Dec 2017 | $7.69 M(+86.1%) | $2.12 M(+5.5%) | $7.69 M(+1.1%) |
| Sep 2017 | - | $2.01 M(+45.5%) | $7.60 M(+23.9%) |
| Jun 2017 | - | $1.38 M(-36.5%) | $6.14 M(+8.8%) |
| Mar 2017 | - | $2.17 M(+6.6%) | $5.64 M(+36.6%) |
| Dec 2016 | $4.13 M(+24.0%) | $2.04 M(+275.1%) | $4.13 M(+47.7%) |
| Sep 2016 | - | $543.70 K(-38.5%) | $2.79 M(-15.2%) |
| Jun 2016 | - | $884.30 K(+33.7%) | $3.30 M(+2.1%) |
| Mar 2016 | - | $661.60 K(-6.2%) | $3.23 M(-3.1%) |
| Dec 2015 | $3.33 M | $705.20 K(-32.5%) | $3.33 M(+26.9%) |
| Sep 2015 | - | $1.04 M(+27.9%) | $2.63 M(+66.1%) |
| Jun 2015 | - | $817.00 K(+7.0%) | $1.58 M(+107.0%) |
| Mar 2015 | - | $763.60 K | $763.60 K |
FAQ
- What is First Wave BioPharma annual SGA?
- What is the all time high annual SGA for First Wave BioPharma?
- What is First Wave BioPharma annual SGA year-on-year change?
- What is First Wave BioPharma quarterly SGA?
- What is the all time high quarterly SGA for First Wave BioPharma?
- What is First Wave BioPharma quarterly SGA year-on-year change?
- What is First Wave BioPharma TTM SGA?
- What is the all time high TTM SGA for First Wave BioPharma?
- What is First Wave BioPharma TTM SGA year-on-year change?
What is First Wave BioPharma annual SGA?
The current annual SGA of FWBI is $10.74 M
What is the all time high annual SGA for First Wave BioPharma?
First Wave BioPharma all-time high annual SGA is $18.38 M
What is First Wave BioPharma annual SGA year-on-year change?
Over the past year, FWBI annual SGA has changed by -$1.25 M (-10.42%)
What is First Wave BioPharma quarterly SGA?
The current quarterly SGA of FWBI is $8.66 M
What is the all time high quarterly SGA for First Wave BioPharma?
First Wave BioPharma all-time high quarterly SGA is $8.66 M
What is First Wave BioPharma quarterly SGA year-on-year change?
Over the past year, FWBI quarterly SGA has changed by +$5.87 M (+210.81%)
What is First Wave BioPharma TTM SGA?
The current TTM SGA of FWBI is -$720.11 M
What is the all time high TTM SGA for First Wave BioPharma?
First Wave BioPharma all-time high TTM SGA is -$8.30 M
What is First Wave BioPharma TTM SGA year-on-year change?
Over the past year, FWBI TTM SGA has changed by -$730.85 M (-6806.51%)